Assistance Publique Hopitaux De Paris
- Address
- lock Available on a paid plan
Assistance Publique Hôpitaux de Paris
Assistance Publique Hôpitaux de Paris (AP-HP) is a leading academic medical institution conducting innovative clinical research across multiple therapeutic areas. The center demonstrates expertise in both acute care interventions and reproductive medicine, advancing evidence-based treatments through rigorous clinical trials.
- Pain management and emergency medicine for hematological disorders
- Reproductive endocrinology and assisted reproductive technologies
- Pediatric emergency care and sickle cell disease complications
The research portfolio includes studies on novel analgesic delivery methods for vaso-occlusive crisis in pediatric sickle cell patients, evaluating intranasal sufentanil administration in emergency settings. Additionally, the center investigates optimization of in vitro fertilization protocols, comparing GnRH agonist-based approaches with conventional hCG induction and luteal phase support strategies to improve live birth outcomes.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Assistance Publique Hopitaux De Paris
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Intranasal Sufentanil and Intravenous Morphine for Analgesia in Pediatric Sickle Cell Vaso-occlusive Crisis: A Randomized Controlled Trial | Assistance Publique Hopitaux De Paris | Phase III | Recruiting | Jul 2025 | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Choriogonadotropin Alfa | 1 | Unknown | 2024-06-27 | 2024-06-27 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.